Clinical Trial Update: Acarbose in Combination With Standard Therapy in Metastatic Renal Cell Carcinoma (RCC) [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating acarbose in combination with standard therapy for metastatic renal cell carcinoma has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• Acarbose (acarbose)

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Kidney Cancer | Phase 2 | Status: WITHDRAWN